23 research outputs found

    UCB-derived CLL-specific T-cells form immunosynaptic complexes with CLL target cells.

    No full text
    <p>(A) UCB-derived CLL-specific T-cells formed immunosynaptic complexes in 72% of conjugation events with CLL cells while naïve T-cells could only form such complexes in 11% of conjugations. Examples of synaptic complex (B) vs. non-synaptic complex (C) are shown. (D) indicates a typical analytic field in which synaptic complexes are identified by white boxes and non-synaptic complexes by red boxes. In practice, at least 20 such field were evaluated for both naïve and expanded lymphocyte populations.</p

    In Vivo Functional Analysis of Partitioned Leukemia-Specific T-cells.

    No full text
    <p>A. Administration of CLL-specific T-cells <i>in vivo</i> to CLL-engrafted mice resulted in a reduction of splenic B-cell burden from 19.3% in untreated or control-treated mice to 4.5% (p = 0.01) among mice treated with CLL-specific T-cells This was statistically indistinguishable from the 2.8% splenic B-cell content of non-CLL engrafted mice. B. Representative flow cytometry plot of splenic CD19<sup>+</sup> cells. Dashed line/unfilled = isotype control. Thick black line/unfilled = CLL engrafted and treated with CLL-specific effectors. Thin black line/gray filled = CLL engrafted but untreated.</p
    corecore